No. As of November 2026, Parmax Pharma Ltd (540359.BO) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Parmax Pharma Ltd does not pass Musaffa's business and financial screening criteria.
Parmax Pharma Ltd. engages in the manufacture of bulk drugs like ampicilin, amoxycillin, cephalexin, and nalidixic acid. The company is headquartered in Rajkot, Gujarat and currently employs 82 full-time employees. The company went IPO on 2017-03-16. The company uses quality by design techniques to produce complex molecules enabling customers to create formulations. The Company’s manufacturing units run in accordance with current good manufacturing practices (cGMP). Its products include Aripiprazole, Lamotrigine I.P., Nebivolol Hydrochloride, Indapamine USP, Voglibos, Ormeloxifene Hydrochloride I.P., Milnacipram HCl, Calciumpoly Carbophil usp, Levosulpride, Paliperidone, Edaravone, Lacosamide, Iloperidone, Prasugrel HCl, 2-Acetyl Thiophene, Morpholine Hydrochloride, Camphor Sulfonyl Chloride, ISB-I (2-Chlorobenzaldehyde-5-Sulfonic acid disodium salt), Benzaldehyde-2, 5-Di-Sulfonic acid disodium salt, 2-picolinoxylidide, 4-Octyl amino pyridine (4-OAP), Sitagliptin phosphate Monohydrate API, Solifenacin Succinate API, Vilazodone Hydrochloride API, and Azelnidipine API.
P
Parmax Pharma Ltd 540359.BO
₹135.00 ₹1.95 (1.47%) 1D
Last Updated: Nov 09, 12:00 AM·BSE
Pricing for IN stocks is delayed by 24 hours
540359.BO Shariah Compliance
Screening Methodology: AAOIFI
As of November 2026, Parmax Pharma Ltd is classified as not halal.
NOT HALAL
Parmax Pharma Ltd (540359.BO) Chart
Fetching Price Chart...
Financial Metrics & Statements of Parmax Pharma Ltd (540359.BO)
FAQ's for Parmax Pharma Ltd (540359.BO)
As of November 2026, Parmax Pharma Ltd 540359.BO is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Parmax Pharma Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Parmax Pharma Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Parmax Pharma Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Parmax Pharma Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Parmax Pharma Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Parmax Pharma Ltd (540359.BO)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.